Angionetics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Angionetics General Information

Description

Developer of biotechnology products for cardiac issues. The company is focused on the development and commercialization of novel DNA-based therapeutics designed to promote the heart's innate natural capacity to modulate the formation and growth of cardiac microvascular circulation to enhance blood flow in patients with a variety of ischemia-driven disease conditions and refractory angina and myocardial ischemia due to cardiac microvascular insufficiency (CMI), and other cardiovascular disease conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11750 Sorrento Valley Road
  • Suite 250
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 11750 Sorrento Valley Road
  • Suite 250
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angionetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angionetics‘s full profile, request access.

Request a free trial

Angionetics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angionetics‘s full profile, request access.

Request a free trial

Angionetics FAQs

  • When was Angionetics founded?

    Angionetics was founded in 2001.

  • Where is Angionetics headquartered?

    Angionetics is headquartered in San Diego, CA.

  • What industry is Angionetics in?

    Angionetics’s primary industry is Biotechnology.

  • Is Angionetics a private or public company?

    Angionetics is a Private company.

  • What is the current valuation of Angionetics?

    The current valuation of Angionetics is .

  • What is Angionetics’s current revenue?

    The current revenue for Angionetics is .

  • Who are Angionetics’s investors?

    Huapont Life Sciences Company, Shenzhen Qianhai Taxus Industry Capital Management, and Taxus Cardium have invested in Angionetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »